Showing results (1971-1980 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|June 18, 2026
Prognostic impact of Dmax on baseline FDG-PET/CT in newly diagnosed multiple myelomaLéo Raffy, Christèle Etchegaray, Elif Hindie, et al.
Haematologica|July 2, 2026
The prognostic implications of autoimmune hemolytic anemia in chronic lymphocytic leukemia across treatment erasYuting Yan, Yongxin Xia, Rui Cui, et al.
Haematologica|July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myelomaTarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Haematologica|July 9, 2026
Response to comment on: "Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience"Jean Galtier, Gaetan Basile, Krimo Bouabdallah
Haematologica|June 25, 2026
Prognostic impact of t(9;11) and del(7q) as intermediate-risk abnormalities in acute myeloid leukemia following allo-transplant: an Acute Leukemia Working Party study from the European Society for Blood and Marrow TransplantationIman Abou Dalle, Jacques-Emmanuel Galimard, Ali Bazarbachi, et al.
Haematologica|July 23, 2026
Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphomaJonathan R Day, Stephen M Ansell
Haematologica|July 23, 2026
Mature plasmacytoid dendritic cell proliferations are also associated with T-cell acute lymphoblastic leukemia: towards an expanding range of associated neoplasmsValentin Pourchet, Xavier Roussel, Sabeha Biichlé, et al.
Haematologica|July 16, 2026
Risk factors and their contributions to prognosis in multiple myelomaTae-Hoon Chung, Jia Geng Chang, Tze King Tan, et al.
Haematologica|July 16, 2026
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignanciesTetiana Perekhrestenko, Anita Badbaran, Evgeny Klyuchnikov, et al.
Haematologica|July 16, 2026
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
Pageof 816